Posicor Lawsuit

Posicor, manufactured by Roche Laboratories, was marketed as a medication to treat hypertension and chronic stable angina pectoris.

The Food and Drug Administration (FDA) approved Posicor despite findings from a congestive heart failure study suggesting that it might fatally disrupt heart rhythm, known as arrhythmia, when used with other drugs.

On June 8, 1998, Roche Laboratories announced a withdrawal of Posicor from the market because of the drug’s risk for serious interactions with other medications.